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scale (WOMAC)Abstract Background: Vitamin K is necessary for the functional activation of vitamin K depen-
dent proteins via gamma-carboxylation process. These proteins are present in bone and cartilage
beside their participation in coagulation cascade.
Aim of the work: This study aimed to assess plasma vitamin K1 (phylloquinone) concentrations
in primary early osteoarthritis (KOA) patients and to correlate these levels with clinical parameters
and radiological progression using plain radiography and musculoskeletal ultrasound (MSUS).
Patients and methods: We measured baseline vitamin K1 in the plasma from 40 early KOA
patients and from 20 healthy controls. In the patients, numerical rating scale of pain (NRSP)
and The Western Ontario McMaster scale (WOMAC) were recorded. The Thomas grading score
and MSUS examination were performed at baseline and after 12 months to assess radiological pro-
gression.
Results: The KOA patients had a mean age of 50.4 ± 4.9 years, 36 females: 4 males and had a
disease duration of 12.7 ± 5.7 months. In KOA patients plasma vitamin K1 levels (1.6 ± 0.9 nmol/
l) were highly signiﬁcantly decreased compared to healthy control (2.04 ± 0.7 nmol/l) (p< 0.05).
In KOA patients, the plasma levels of vitamin K1 signiﬁcantly correlated with baseline medial con-
dyle cartilage thickness (r= 0.46, p< 0.05), and vitamin K deﬁciency had a signiﬁcantly increased
risk of radiological progression as assessed by MSUS (p= 0.004) (twofold increased risk, RR 2.08).
Conclusions: Knee osteoarthritis patients have signiﬁcantly decreased plasma levels of vitamin K
that was remarkably associated with radiological progression of early disease suggesting that it could
be a useful marker to reﬂect OA severity and implies a possible role in the disease pathogenesis.
 2016 Egyptian Society of Rheumatic Diseases. Publishing services provided by Elsevier B.V. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Osteoarthritis (OA) has been found to affect the whole joint as
pathological abnormalities are not only conﬁned to cartilage
destruction and bone remodeling but also include low grade
synovitis, lax ligaments, periarticular muscle weakness and
neurosensory system affection [1]. These features lead to devel-
opment of manifestations such as pain, muscle weakness, and
limited mobility and may progress over time to functional
disability [2]. In Egyptian patients with knee OA (KOA) many
factors play a role in the disease pathogenesis including cytoki-
nes [3], oxidative stress [4]. Vascular endothelial growth factor
was remarkably associated with the radiological changes of
KOA [5] and osteopontin served as another biomarker of
disease severity and was predictive of the disease [6] and radi-
ological progression [7].
Vitamin K represents a family of related molecules that
have a common structure and carboxylation activity. This
family includes three compounds: vitamin K1 (Phylloqui-
none) that is found in food from plant origin, vitamin K2
(Menaquinone) that is of a bacterial by-product origin and
is found in fermented products and vitamin K3 (Menadione)
that is a synthetic compound found only in dietary
supplements [8]. About 17 vitamin K-dependent proteins
or c-carboxyglutamate (Gla) proteins are known and their
activation is carried out by gamma carboxylation of their
glutamate residue mediated by vitamin K [9]. Most of vita-
min K dependent proteins are involved in the coagulation
cascade and the function of some of them is still unknown
[10]. However, some are constituents of bone and extracellu-
lar matrix such as osteocalcin (OC), matrix Gla protein
(MGP) and growth arrest speciﬁc gene 6 protein (Gas 6)
and they act as a regulator of bone mineralization and
calciﬁcation of soft tissues as well as stimulation of cell pro-
liferation [8,11]. Deﬁciency of vitamin K leads to decrease in
the functional forms of vitamin K dependent proteins that
can affect chondrocyte differentiation and endochondral
bone formation, a possible underlying mechanism of osteo-
phyte formation [12,13]. Thus, vitamin K deﬁciency may
play a potential role in the pathophysiology of OA [14].
Plain radiography has been used as the initial imaging
modality for assessment of OA; it is considered a helpful tool
for evaluation of narrowing of the joint space, osteophytes and
sclerosis [15]. But on the other hand, there are limitations in
direct visualization of the hyaline cartilage, menisci and
involvement of periarticular soft tissue. The changes detected
by plain radiography are not only speciﬁc to OA but may be
found also in asymptomatic elderly people [16].
Musculoskeletal ultrasound (MSUS) is now considered an
important imaging modality for assessment of various joint
pathologies as it has the ability for direct visualization of the
hyaline articular cartilage, menisci, synovial membrane, bursa
and the bone cortex [17]. In OA, it is used to demonstrate
many pathological changes that occur due to structural dam-
age and inﬂammation. Synovial inﬂammation appears in the
form of joint effusion and synovial hypertrophy and structural
damage appears in the form of cartilage lesions and osteo-
phytes [18]. So, MSUS is considered a cheap, non-invasive, fast
imaging modality that is ideal for early diagnosis and monitor-
ing of disease progression of OA especially in joints with wide
acoustic window such as the knee [19,20].This study aimed to assess plasma vitamin K1 (phylloqui-
none) concentrations in primary KOA patients and to corre-
late these levels with clinical parameters and radiological
progression of OA using plain radiography and MSUS.
2. Patients and methods
Forty patients with primary KOA, fulﬁlling the American
College of Rheumatology (ACR) criteria for the classiﬁcation
and reporting of OA of the knee [21] were recruited from the
in-patients and out–patients’ clinic of the Rheumatology and
Rehabilitation Department of Benha University Hospitals. 20
age and sex matched apparently healthy individuals from the
hospital personnel; medical and nursing staffs were also included
as a control group. Only patients with early OA, who fulﬁll the
following inclusion criteria [22] were incorporated in the study:
age between 35 and 65 years, pain on most days (i.e., at least
4 days in a week) in 1 or both knees for at least 4 months during
the preceding year, symptoms duration less than 5 years, grade
II or less OA radiographic stage in at least 1 knee as deﬁned
by Kellgren and Lawrence (K/L) grading scale [23]. We excluded
patients with primary late KOA (K/L scale > 2), patients with
secondary KOA and patients with conditions that affect vitamin
K status as coagulation disorders, liver diseases and patients
receiving oral anticoagulant medications. The local ethics com-
mittee of our institution (Benha University, Faculty of Medicine)
approved the study and all participants gave a written informed
consent before being enrolled in this study.
Patients’ evaluation included full history taking and
thorough physical examination, with particular focus on pain
evaluation using numerical rating scale of pain (NRSP) [24]
and recording of the disease duration and ongoing medica-
tions, the presence of effusion and range of motion assessment.
Body mass index (BMI) and Western Ontario and McMaster
Universities (WOMAC) composite index to assess pain and
disability [25] were assessed in all patients.
2.1. Radiological assessment
Plain radiographs of both knees, anteroposterior standing
view with 20 knee ﬂexion and skyline view for assessment of
patellofemoral compartment, were taken at baseline and after
12 months. Two radiographic methods were used for evalua-
tion: K/L criteria were used at baseline to categorize OA for
inclusion in the study and Thomas score [26] was used to
evaluate radiographic progression. We did not use K/L criteria
in assessment of radiographic progression as it takes 2 years at
least for progression from one K/L grade to a higher
grade. Thomas score was used for evaluation of medial, lateral
and patellofemoral compartments. Each compartment was
evaluated for degree of narrowing of the joint space, osteo-
phyte formation subchondral sclerosis and bone cysts. Each
item is graded from 0 to 3 and then the score of each compart-
ment is calculated by the summation of the score of the 4 items
on the right and left sides followed by calculation of the total
score by summation of the score of the 3 compartments.
2.2. Musculoskeletal ultrasound
A commercially available Logiq e real-time scanner (General
Electric Medical Systems, Milwaukee, Wisconsin, USA) was
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frequency (8–13 MHz) linear transducer. Grayscale examina-
tion of the femoral articular cartilage was performed according
to Saarakkala et al. [27] with the subject in the supine position
and the knee fully ﬂexed. The transducer should be placed
transversely on the intercondylar notch area just above the
patella for measurement and evaluation of hyaline cartilage
in intercondylar (sulcus) area, medial and lateral femoral con-
dyles area, and then the following OA ultrasonic grades are
given: Grade 0: anechoic band with sharp hyperechoic carti-
lage interfaces. Grade 1: loss of cartilage interfaces sharpness
and/or increased cartilage echogenicity and this represents
mild degenerative changes. Grade 2A (Moderate degenerative
changes): in addition to the previous changes, less than 50%
thinning of the hyaline cartilage was found and this represents
moderate degenerative changes. Grade 2B: degenerative
changes were as follows: cartilage thinning was found to be
more than 50% and less than 100%. Grade 3: loss of 100%
of cartilage thickness and this represents severe degenerative
change. Then, Medial and lateral longitudinal scans were per-
formed with the patient in supine position with the knee in
extension or slight ﬂexion (20–30) to detect excess ﬂuid collec-
tion and/or osteophytes.
The evaluation of plain radiography and ultrasound exam-
ination was performed by 2 observers and one of the observers
was blinded to the condition of the patients and radiological
progression was considered if there is an increase in Thomas
score or US transition to higher grade at the 12 months
follow-up period as compared to baseline score.2.3. Measurement of plasma levels of vitamin K1
(Phylloquinone)
Plasma was collected at baseline evaluation after 10 h fasting
from KOA patients and controls in heparinized tubes and
stored at 80 C until analysis. Assay of sPD-1 was made by
the enzyme linked immunosorbent assay (ELISA) technique
using the kit supplied from (SunRed, Shanghai, China)
Human Vitamin K1 (VK1) ELISA Kit Cat. No: 201–12-
1115. The assay procedures were followed according to the
manufacturer’s instructions. The detection range is 0.1–
20 ng/ml which is equivalent to 0.22–44.4 nmol/l. Deﬁciency
of vitamin K1 is considered if vitamin K1 level is below
0.5 nmol/l as normal vitamin K plasma levels range between
0.5 nmol/l and 2.5 nmol/l [28].Table 1 Comparison between knee osteoarthritis (KOA) patients an
plasma levels at baseline evaluation.
Variable mean ± SD (range) or n (%) KOA patients (n=
Sex F:M 36:4 (90:10)
Age (years) 50.4 ± 4.9 (41–60
BMI 29.04 ± 3.6 (23.4–
Obese (BMIP 30) 14 (35)
Disease duration (mo) 12.7 ± 5.7 (5–24)
Baseline Vit. K (nmol/l) 1.6 ± 0.9 (0.25–3.
Deﬁcient* 11 (27.5)
Suﬃcient 29 (72.5)
KOA: knee osteoarthritis, F:M: Female:Male, BMI: body mass index.
* Deﬁned based upon plasma phylloquinone concentrations 6 0.5 nmo2.4. Statistical analysis
The statistical analysis was conducted using Statistical
Package of Social Sciences (SPSS) 16.0 for Windows (SPSS,
Inc., Chicago, IL, USA). The collected data were summarized
in terms of mean ± standard deviation (SD) for quantitative
data and frequency and percentage for qualitative data.
Chi-square test (v2) and Fisher’s Exact Test (FET) were used
to compare frequencies as appropriate. Student t-test was used
to detect mean differences between two groups regarding
quantitative data. The Risk Ratio (RR) for radiological pro-
gression of OA among patients with deﬁcient and sufﬁcient
vitamin K was estimated. Receiver Operating Curve (ROC)
analysis was carried out to evaluate the diagnostic perfor-
mance of vitamin K levels for OA progression. The best cutoff
point and the corresponding sensitivity and speciﬁcity and
Area under the Curve (AUC) were estimated. Pearson correla-
tion coefﬁcient was used. Statistical signiﬁcance was accepted
at p value < 0.05.
3. Results
Forty KOA patients with a mean age of 50.4 ± 4.9 years and
20 matched control were included in the study. The mean
disease duration in KOA patients was 12.7 ± 5.7 months
being comparable between vitamin K deﬁcient and sufﬁcient
patients (14.5 ± 5.7 and 11.8 ± 5.4 months respectively).
Patients’ clinical and laboratory features at baseline are shown
in Table 1. Physical ﬁndings of knee examination and the
ultrasound ﬁndings at baseline and after 12 months in vitamin
K deﬁcient and sufﬁcient KOA patients are shown in Table 2.
Fig. 1 shows loss of the normal sharpness of the knee
suprapatellar cartilage interfaces and increased echogenicity
(grade 1) assessed by MSUS.
Radiological evaluation at baseline and after 12 months
(Table 3) showed a signiﬁcant increase in the medial compart-
ment and total Thomas score after 12 months in vitamin K
deﬁcient KOA patients (Baseline: 3.4 ± 1.6 and 5.7 ± 2.3;
after 12 months: 4.9 ± 2.6 and 8.3 ± 4.5, respectively).
Baseline US examination showed a signiﬁcantly decreased
medial condyle cartilage thickness in the vitamin K deﬁcient
KOA patients compared to the vitamin K sufﬁcient patients
(p< 0.05). There was a signiﬁcant decrease in medial condyle,
lateral condyle and sulcus cartilage thickness in vitamin K
deﬁcient KOA patients while in sufﬁcient vitamin K patients,d controls as regards demographic characteristics and vitamin K
40) Controls (n= 20) p
17:3 (85:15) 0.68
) 48.9 ± 4.6 (42–58) 0.26
36) 24.3 ± 1.3 (21.3–27.1) <0.001
0 (0)
– –
1) 2.04 ± 0.7 (0.3–2.9) 0.038
1 (5) 0.047
19 (95)
l/l, bold values are signiﬁcant at p< 0.05.
Table 2 Physical ﬁndings in knee examination and ultrasound grading and ﬁndings at baseline evaluation and after 12 months in
KOA patients in relation to deﬁcient and sufﬁcient vitamin K levels.
KOA patients (n= 40) mean ± SD (range) or n (%) Vitamin K: deﬁcient (n= 11), suﬃcient (n= 29)
Baseline After 12 month
Deﬁcient Suﬃcient Deﬁcient Suﬃcient
(22 knees) (58 knees) (22 knees) (58 knees)
Knee examination
Swelling No 19 (86.4) 52 (89.7) 16 (72.7) 51 (87.9)
Mild 3 (13.6) 6 (10.4) 4 (18.2) 4 (6. 9)
Moderate 0 (0) 0 (0) 2 (9.1) 3 (5.2)
P 0.7 0.2
Stiﬀness (min) 3.04 ± 1.9 3.03 ± 2.2 5.2 ± 3.1 3.95 ± 3.1
(0–7) (0–8) (0–12) (0–12)
P 0.98 0.12
Crepitus 1 (4.6) 1 (1.7) 7 (31.8) 8 (13.8)
P 0.48 0.1
NRSP 2.4 ± 0.5 2.3 ± 0.6 5.1 ± 0.7 3.3 ± 1.5
(2–3) (1–4) (4–6) (1–6)
P 0.8 <0.001
WOMAC 22.6 ± 2.3 17.8 ± 4.4 28.2 ± 3.6 19.9 ± 5.9
(19–26) (11–27) (21–34) (12–33)
P 0.001 <0.001
Knee ultrasound
US grading 0 5 (22.7) 13 (22.4) 2 (9.1) 12 (20.7)
1 14 (63.6) 36 (62.1) 6 (27.3) 28 (48.3)
2A 3 (13.6) 9 (15.5) 10 (45.5) 10 (17.2)
2B 0 (0) 0 (0) 4 (18.2) 8 (13.8)
P >0.05 <0.05
Osteophytes 7 (31.8) 10 (17.2) 10 (45.5) 12 (20.7)
P 0.2 0.047
Eﬀusion 6 (27.3) 5 (8.6) 5 (22.7) 6 (10.3)
P 0.06 0.16
KOA: knee osteoarthritis; NRSP: numerical rating scale of pain; WOMAC: Western Ontario McMaster scale. Bold values are signiﬁcant at
p< 0.05.
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(Table 3). There was no signiﬁcant difference in the percentage
of knees showing radiological progression after 12 monthsFigure 1 Suprapatellar transverse ultrasound scan in a 42-year-
old male KOA patient showing the measurement of femoral
hyaline cartilage: (1) at medial femoral condyle; (2) at sulcus area;
(3) at lateral femoral condyle. There is loss of the normal
sharpness of cartilage interfaces and increased echogenicity of the
cartilage (grade 1).between vitamin K deﬁcient and sufﬁcient KOA patients
assessed by Thomas score. There was a signiﬁcantly increased
radiological progression in those with deﬁcient (68.2%) com-
pared to those with sufﬁcient vitamin K assessed by ultrasound
after 12 months. There was a twofold increased risk of radio-
logical progression (RR 2.08, 95% CI, 1.30–3.32) after adjust-
ing for age, sex and BMI (Table 3).
The best cutoff of vitamin K for radiological progression by
plain radiography was 1.74 nmol/l (sensitivity: 54.6%; speci-
ﬁcity: 58.6%) and area under the curve (AUC) of 0.57 at the
95%CI (Fig. 2A), while the best cutoff by US was
1.28 nmol/l (sensitivity: 72%; speciﬁcity: 53.3%) and AUC of
0.72 at the 95% CI (Fig. 2B).
Plasma vitamin K1 levels showed a signiﬁcant correlation
with the medial condyle cartilage thickness at baseline
(r= 0.46, p< 0.05) (Fig. 3). There was no other signiﬁcant
correlation between vitamin K1 plasma levels and other dis-
ease parameters.
4. Discussion
Vitamin K assessment appears to be a relatively difﬁcult issue
compared with most of other micronutrients as it is a group of
structurally related molecules rather than a single molecule;
however, in humans, vitamin K1 is considered the main source
of vitamin K activity [29]. Vitamin K, in its reduced form, acts
Table 3 Comparison between vitamin K deﬁcient and sufﬁcient KOA patients as regards plain radiography using Thomas score and
femoral cartilage thickness measured with US at baseline evaluation and after 12 months and regarding radiological progression.
Variable mean ± SD or n (%) Vitamin level in KOA patients (n= 40)
Deﬁcient* (n= 11) Suﬃcient (n= 29)
Thomas score Compartment
Medial Baseline 3.4 ± 1.6 3.96 ± 1.8
After 12 mo 4.9 ± 2.6 4.1 ± 1.8
p 0.009 0.1
Lateral Baseline 1.6 ± 0.9 2.1 ± 1.5
After 12 mo 2.2 ± 1.4 2.3 ± 1.5
p 0.17 0.06
Patellofemoral Baseline 0.7 ± 0.5 0.9 ± 0.8
After 12 mo 1.2 ± 0.9 1.03 ± 0.9
P 0.05 0.08
Total score Baseline 5.7 ± 2.3 7.03 ± 3.6
After 12 mo 8.3 ± 4.5 7.3 ± 3.6
P 0.01 0.06
Radiological progression 3 (13.6) 5 (8.6)
p (RR;95% CI) 0.68 (1.58; 0.4–6.1)
Ultrasound Cartilage thickness (cm)
Medial Condyle Baseline 0.22 ± 0.017 0.23 ± 0.016
After 12 mo 0.19 ± 0.03 0.22 ± 0.02
P <0.001 0.005
Lateral condyle Baseline 0.255 ± 0.009 0.252 ± 0.01
After 12 mo 0.251 ± 0.01 0.251 ± 0.01
P 0.03 0.16
Sulcus Baseline 0.245 ± 0.01 0.238 ± 0.01
After 12 mo 0.242 ± 0.01 0.237 ± 0.01
P 0.04 0.08
Radiological progression 15 (68.2) 19 (32.8)
p (RR;95% CI) 0.004 (2.1; 1.3–3.3)
KOA: knee osteoarthritis.
* Deﬁned based upon plasma phylloquinone concentrations 6 0.5 nmol/l, bold values are signiﬁcant at p< 0.05.
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boxylates glutamic acid residues in vitamin K–dependent pro-
teins [30]. c-Carboxylation of Gla proteins enables them to
bind calcium, ensuring Gla domain proper folding and assists
binding to cell membranes [31,32].
It is well established that the usage of warfarin, a vitamin
K-antagonist anticoagulant, in early pregnancy can cause war-
farin embryopathy manifested by atypical calciﬁcation and
decreased cartilage growth [33]. It has been suggested that vita-
min K deﬁciency possibly contributes to the pathogenesis and
progression of OA especially as it has many effects on articular
hyaline cartilage and subchondral bone that may have a poten-
tial role in pathological changes as chondrocyte hypertrophy
and endochondral ossiﬁcation [34–36] Contrarily, in another
study it has been demonstrated that vitamin K supplementa-
tion did not have a beneﬁcial effect on OA patients [14].
In the present study, 27.5% of the KOA patients were vita-
min K deﬁcient at baseline compared to 5% of healthy con-
trols and the mean plasma vitamin K1 levels was
signiﬁcantly decreased. These results conﬁrmed those of Neogi
et al. [37], who found an association between increased preva-
lence of OA and low plasma vitamin K (phylloquinone) below
1 nmol/l. McCann and Ames [29] suggested a mechanism
called the triage principle that states that, at time of decreased
intake, a transport system ensures supply of trace elements and
vitamins mainly to the sites of more vital function which is theliver in case of vitamin K to decrease the risk of bleeding. So
only when vitamin K is sufﬁcient in the liver, extra-hepatic
transportation of vitamin K can occur. It is expected that vita-
min K dependent proteins at extra-hepatic sites to be the ﬁrst
affected by suboptimal intake of vitamin K and McCann and
Ames concluded that prolonged vitamin deﬁciencies can con-
tribute to the pathophysiology of age-related disorders.
In the current study, KOA patients with vitamin K deﬁ-
ciency had an increased risk of radiological progression as
assessed by X-ray and ultrasound as compared to patients with
sufﬁcient vitamin K plasma levels. Shea et al. [38] found OA
patients who were vitamin K deﬁcient to be more susceptible
to articular cartilage and menisci damage after 36 months
follow-up and suggested that vitamin K determines carboxyla-
tion but not expression of vitamin K dependent proteins. Vita-
min K insufﬁciency can impair the function of many vitamin
K-dependent proteins that may contribute to the pathogenesis
of OA through many possible mechanisms. One possible
mechanism is the impaired chondrocyte viability due to
decreased Gas-6 functional activation [39]. Also, deﬁciency
of MGP, a vitamin K dependent protein that inhibits ectopic
calciﬁcation, can produce calciﬁcation of growth end plate in
a process that can be similar to that of osteophyte formation.
Furthermore, MGP binds to bone morphogenetic protein 2
leading to inhibition of chondrogenesis [38]. Wallin et al. [40]
found OA chondrocytes to produce functionally inactive
Figure 2 Receiver operating characteristic (ROC) curve assessing the validity of the vitamin K in prediction of OA radiological
progression. (A) Plain radiography: the area under the curve (AUC) was 0.57 at 95%CI. (B) US: the AUC was 0.72 at 95%CI.
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cartilage thickness in KOA patients.
222 Abd-El Wahab S. El-Brashy et al.MGP while normal chondrocytes produced the functional car-
boxylated MGP and this was attributed to decreased c-
carboxylase activity in OA chondrocytes that was ﬁve-times
less than its activity in OA chondrocytes.
In contrast to our results, in the study by Neogi et al. [14] it
has been found that vitamin K supplementation for 3 years did
not give overall added beneﬁt to patients with hand OA; how-
ever, they found OA patients, who were vitamin K deﬁcient at
baseline and became sufﬁcient at follow-up, to have 47%
decrease in joint space narrowing. They attributed this discrep-
ancy to the relative small percentage (33%) of baseline vitamin
K deﬁcient OA patients and thus one would not anticipate an
effect over the overall study participants.
In our study the difference in radiological progression
between vitamin K deﬁcient and sufﬁcient OA patients was
more evident when assessment was performed with MSUS
rather than plain radiography. This can be explained as MSUS
is more sensitive than plain radiography in early detection of
early degenerative changes due to its ability of direct visualiza-
tion of the hyaline cartilage. Saarakkala et al. [27] found a sig-
niﬁcant correlation between pathological cartilage ﬁnding in
US of the knee and arthroscopic degenerative cartilagechanges and suggested that MSUS can predict severity of
degenerative changes of hyaline cartilage especially in the med-
ial femoral condyle and sulcus area. Previous studies investi-
gated the relation between deﬁciency of vitamin K and
radiological features of OA and other studies evaluated the
effect of vitamin K supplementation on OA progression. Only
2 previous studies have longitudinally assessed the relationship
between vitamin K and radiological progression of OA [28,39].
A limitation of our results lies in the small number of
patients included in the study. Another limitation is the rela-
tively short duration of the follow-up period. Further longitu-
dinal studies are recommended with a larger number of
patients to deﬁne the exact role of vitamin K in the occurrence
and progression of OA and to establish whether vitamin K
supplementation could be a useful treatment option for
osteoarthritis.
In conclusion, Knee osteoarthritis patients have signiﬁ-
cantly decreased plasma levels of vitamin K that was remark-
ably associated with radiological progression of early disease
suggesting that it could be a useful marker to reﬂect OA sever-
ity and implies a possible role in the pathogenesis of OA. US is
more sensitive than plain radiography in the detection of
degenerative cartilage abnormality of KOA patients.
Conflict of interest
Authors declare no conﬂict of interest.
References
[1] Jeremie S, Gabriel H, Frances B. Osteoarthritis: pathogenesis,
clinical aspects and diagnosis. Eular Compend Rheum Dis
2009;30:444–63.
[2] Palmer S, Domaille M, Cramp F, Walsh N, Pollock J, Kirwan J,
et al. Transcutaneous electrical nerve stimulation as an adjunct to
education and exercise for knee osteoarthritis: a randomised
controlled trial. Arthritis Care Res (Hoboken) 2014;66(3):387–94.
[3] Hussein NA, Sharara G. Correlation between serum leptin,
cytokines, cartilage degradation and functional impact in obese
kneeosteoarthritis patients. Egypt Rheumatologist 2016;38(2):
117–22.
[4] El-barbary AM, Abdel Khalek MA, Elsalawy AM, Hazaa SM.
Assessment of lipid peroxidation and antioxidant status in
Role of vitamin K in radiological progression of early knee osteoarthritis patients 223rheumatoid arthritis and osteoarthritis patients. Egypt Rheuma-
tologist 2011;33(4):179–85.
[5] Gaballah A, Hussein NA, Risk M, Elsawy N, Elabasiry S.
Correlation between synovial vascular endothelial growth factor,
clinical, functional and radiological manifestations in knee
osteoarthritis. Egypt Rheumatologist 2016;38(1):29–34.
[6] Haider HM, Amin IR, Ahmad KA. Plasma and synovial
osteopontin levels, are they associated with disease severity of
primary kneeosteoarthritis in Egyptian patients? Egypt Rheuma-
tologist 2015;37(1):29–34.
[7] Mohammed FI, Abd El-Azeem MI, KamalElDin AM. Plasma
and synovial ﬂuid osteopontin levels in patients with knee
osteoarthritis: relation to radiological grade. Egypt Rheumatol-
ogist 2012;34(3):131–6.
[8] Berkner KL, Runge KW. The physiology of vitamin K nutriture
and vitamin K-dependent protein function in atherosclerosis. J
Thromb Haemost 2004;2:2118–32.
[9] Vermeer C. Gamma-carboxyglutamate-containing proteins and
the vitamin K-dependent carboxylase. Biochem J 1990;266
(3):625–36.
[10] Brandenburg VM, Schurgers LJ, Kaesler N, Pu¨sche K, van Gorp
RH, Leftheriotis G, et al. Prevention of vasculopathy by vitamin
K supplementation: can we turn ﬁction into fact? Atherosclerosis
2015;240(1):10–6.
[11] Loeser R, Varnum B, Carlson C, Goldring MB, Liu ET, Sadiev S,
et al. Human chondrocyte expression of growth-arrest-speciﬁc
gene 6 and the tyrosine kinase receptor axl: potential role in
autocrine signaling in cartilage. Arthritis Rheum 1997;40:1455–65.
[12] Bullough PG. The pathology of osteoarthritis. In: Moskowitz
RW, Howell DS, Goldberg MS, Mankin HJ, editors. Osteoarthri-
tis: diagnosis and medical/surgical management. Philadelphia:
WB Saunders; 1992. p. 39–69.
[13] Newman B, Gigout LI, Sudre L, Grant ME, Wallis GA.
Coordinated expression of matrix Gla protein is required during
endochondral ossiﬁcation for chondrocyte survival. J Cell Biol
2001;154:659–66.
[14] Neogi T, Felson DT, Sarno R, Booth SL. Vitamin K in hand
osteoarthritis: results from a randomised clinical trial. Ann
Rheum Dis 2008;67(11):1570–3.
[15] Meenagh G, Filippucci E, Iagnocco A, Delle Sedie A, Riente L,
Bombardieri S, et al. Ultrasound imaging for the rheumatologist
VIII. Ultrasound imaging in osteoarthritis. Clin Exp Rheumatol
2007;25:172–5.
[16] Hunter DJ, Conaghan PG. Imaging outcomes and their role in
determining outcomes in osteoarthritis and rheumatoid arthritis.
Curr Opin Rheumatol 2006;18:157–62.
[17] Naredo E, Acebes C, Mo¨ller I, Canillas F, de Agustı´n JJ, de
Miguel E, et al. Ultrasound validity in the measurement of knee
cartilage thickness. Ann Rheum Dis 2009;68:1322–7.
[18] Iagnocco A. Imaging the joint in osteoarthritis: a place for
ultrasound? Best Pract Res Clin Rheumatol 2010;24(1):27–38.
[19] Grassi W, Filippucci E, Farina A. Ultrasonography in
osteoarthritis. Semin Arthritis Rheum 2005;34:19–23.
[20] Mo¨ller I, Bong D, Naredo E, Filippucci E, Carrasco I, Moragues
C, et al. Ultrasound in the study and monitoring of osteoarthritis.
Osteoarthritis Cartilage 2008;16(Suppl 3):S4–7.
[21] Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K,
et al. Development of criteria for the classiﬁcation and reporting
of osteoarthritis. Classiﬁcation of osteoarthritis of the knee.
Diagnostic and Therapeutic Criteria Committee of the American
Rheumatism Association. Arthritis Rheum 1986;29:1039–49.
[22] Farr JN, Going SB, Lohman TG, Rankin L, Kasle S, Cornett M,
et al. Physical activity levels in patients with early knee osteoarthritis
measured by accelerometry. Arthritis Rheum 2008;59(9):1229–36.
[23] Kellgren JH, Lawrence JS. Radiological assessment of osteo-
arthrosis. Ann Rheum Dis 1957;16:494–502.[24] Ferraz MB, Quaresma MR, Aquino LR, Atra E, Tugwell P,
Goldsmith H. Reliability of pain scales in the assessment of
literate and illiterate patients with rheumatoid arthritis. J
Rheumatol 1990;17(8):1022–4.
[25] Guermazi M, Poiraudeau S, Yahia M, Mezganni M, Fermanian J,
Habib Elleuch M, et al. Translation, adaptation and validation of
the Western Ontario and McMaster Universities osteoarthritis
index (WOMAC) for an Arab population: the Sfax modiﬁed
WOMAC. Osteoarthritis Cartilage 2004;12(6):459–68.
[26] Thomas RH, Resnick D, Alazraki NP, Daniel D, Greenﬁeld R.
Compartmental evaluation of osteoarthritis of the knee. A
comparative study of available diagnostic modalities. Radiology
1975;116(3):585–94.
[27] Saarakkala S, Waris P, Waris V, Tarkiainen I, Karvanen E,
Aarnio J, et al. Diagnostic performance of knee ultrasonography
for detecting degenerative changes of articular cartilage.
Osteoarthritis Cartilage 2012;20:376–81.
[28] Misra D, Booth SL, Tolstykh I, Felson DT, Nevitt MC, Lewis
CE, et al. Vitamin K deﬁciency is associated with incident knee
osteoarthritis. Am J Med 2013;126:243–8.
[29] McCann JC, Ames BN. Vitamin K, an example of triage theory: is
micronutrient inadequacy linked to diseases of aging? Am J Clin
Nutr 2009;90:889–907.
[30] Berkner KL. Vitamin K-dependent carboxylation. Vitam Horm
2008;78:131–56.
[31] Freedman SJ, Blostein MD, Baleja JD, Jacobs M, Furie BC, Furie
B. Identiﬁcation of the phospholipid binding site in the vitamin K-
dependent blood coagulation protein factor IX. J Biol Chem
1996;271:16227–36.
[32] Freedman SJ, Furie BC, Furie B, Baleja JD. Structure of the
metal-free gamma-carboxyglutamic acid-rich membrane binding
region of factor IX by two-dimensional NMR spectroscopy. J Biol
Chem 1995;270:7980–7.
[33] Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, Behringer RR,
et al. Spontaneous calciﬁcation of arteries and cartilage in mice
lacking matrix GLA protein. Nature 1997;386:78–81.
[34] Silveira DB, da Rosa EB, de Mattos VF, Goetze TB, Sleifer P,
Santa Maria FD, et al. Importance of a multidisciplinary
approach and monitoring in fetal warfarin syndrome. Am J
Med Genet A 2015;167(6):1294–9.
[35] Shea MK, Booth SL, Massaro JM, Jacques PF, D’Agostino Sr
RB, Dawson-Hughes B, et al. Vitamin K and vitamin D status:
associations with inﬂammatory markers in the Framingham
Offspring Study. Am J Epidemiol 2008;167:313–20.
[36] Yagami K, Suh JY, Enomoto-Iwamoto M, Koyama E, Abrams
WR, Shapiro IM, et al. Matrix GLA protein is a developmental
regulator of chondrocyte mineralization and when constitutively
expressed, blocks endochondral and intramembranous ossiﬁca-
tion in the limb. J Cell Biol 1999;147:1097–108.
[37] Neogi T, Booth S, Zhang Y, Jacques PF, Terkeltaub R, Aliabadi
P, et al. Low vitamin K status is associated osteoarthritis in the
hand and knee. Arthritis Rheum 2006;54:1255–61.
[38] Shea MK, Kritchevsky SB, Hsu FC, Nevitt M, Booth SL, Kwoh
CK, et al. The association between vitamin K status and knee
osteoarthritis features in older adults: the health, aging and body
composition study. Osteoarthritis Cartilage 2015;23(3):370–8.
[39] Haﬁzi S, Dahlba¨ck B. Gas6 and protein S: Vitamin K-dependent
ligands for the Axl receptor tyrosine kinase subfamily. FEBS J
2006;273:5231–44.
[40] Wallin R, Schurgers LJ, Loeser RF. Biosynthesis of the vitamin
K-dependent matrix Gla protein (MGP) in chondrocytes: a fetuin-
MGP protein complex is assembled in vesicles shed from normal
but not from osteoarthritic chondrocytes. Osteoarthritis Cartilage
2010;18(8):1096–103.
